Targeting membrane androgen receptors in tumorsTherapeutic opportunities for targeting the ubiquitous cell surface receptor CD47Virus maturation as a new HIV-1 therapeutic targetTargeting selectins and selectin ligands in inflammation and cancerThe 5-HT3 receptor as a therapeutic targetBitter taste receptors on airway smooth muscle as targets for novel bronchodilatorsThe DNA helicase-primase complex as a target for herpes viral infectionProtein-based therapies for acute lung injury: targeting neutrophil extracellular trapsROCKs as immunomodulators of strokeTargeting JAK2 in the therapy of myeloproliferative neoplasmsTargeting disease through novel pathways of apoptosis and autophagyTargeting the Bcl-2 family for cancer therapyTargeting the Fc receptor in autoimmune diseaseRon receptor tyrosine kinase signaling as a therapeutic targetPDE4 as a target for cognition enhancementTargeting TGF-β signaling in cancerCXCR2: a target for pancreatic cancer treatment?Targeting Cdc42 in cancerTargeting the RAS oncogene.Therapeutic targets for the treatment of hepatitis E virus infectionHIV-1 gp120 as a therapeutic target: navigating a moving labyrinthMicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4Pathophysiological roles for IL-18 in inflammatory arthritisThe role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?Therapeutic effects of nitric oxide-aspirin hybrid drugsThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesPigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular diseaseSterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?The endothelin system and its role in acute myocardial infarction14-3-3 zeta as novel molecular target for cancer therapyPAK as a therapeutic target in gastric cancerNeurotrophic factors as a therapeutic target for Parkinson's diseaseTargeting survivin in cancer therapyNav1.7 and other voltage-gated sodium channels as drug targets for pain reliefLSD1 inhibition: a therapeutic strategy in cancer?Targeting CXCR1/CXCR2 receptor antagonism in malignant melanomaKetamine's antidepressant action: beyond NMDA receptor inhibitionIL-23: changing the verdict on IL-12 function in inflammation and autoimmunityFunctional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaPhosphodiesterase-4 as a potential drug target
P1433
Q22306017-5C6EED38-06C8-4FB7-B3D4-2813E2A7DFAFQ24627155-70CF54F8-534D-46D8-A908-386034201654Q24642446-220F3883-80CC-467D-B6D4-5D260F4CDE2FQ24658204-4FA92A1B-EA13-4BC0-BD27-B95F23623A7CQ24681066-7ABD00D9-1090-4A38-A2EA-52282828EB4AQ26830082-7175C258-D7DD-4683-9A40-E90372C0CB6BQ26849412-649E2C86-52D2-4E47-A001-B0E5F09E59B1Q26852032-7A6137E6-F43D-4AD3-BD08-02E437FBBFE5Q26853214-3AA896B1-5EAF-4662-9E5A-9775169F74B0Q26860796-82A91E90-9C9A-4817-AE4A-39194FD314EAQ26864639-F1491EB6-1BE1-4085-BA59-55875A344ED6Q26866936-0E7E373B-8224-4F66-BAC0-439E47702AF1Q27002843-F7B3634A-ABDC-4E94-9E28-254A0875C64DQ27003295-D4720378-8CBB-422A-BDEB-8AEB0516817DQ27008296-921D1CC9-B922-4132-9027-241300B32B35Q27012443-8BAFA4ED-25E2-4396-9867-92FFE6B74888Q27021588-6195D220-F081-4B7D-A926-4193FA672A3BQ27028075-34474370-562C-4B59-914D-C19373599947Q27687198-36D40EC6-5E42-4133-A92E-1134C5BEC863Q28084036-F154CC34-6A1E-473E-B84B-7FECF2FD1E0BQ28086826-9AF7CFF4-C2AD-4793-B79A-197F29A4E514Q28118775-A44641DD-FB37-464B-BC54-ABF2E37E8154Q28187644-98BC1E42-A111-4589-8B04-D7F98A63D483Q28201093-D1F15DFF-762B-4CB5-98CA-23DB3190830BQ28210282-55F1AB83-D217-4279-B16F-6353785E6EECQ28238709-85F3BEDC-53D4-4D32-8A75-2052BB4FDA37Q28255757-9F80AB4A-F215-4692-8BC3-3CED4EB882A8Q28257929-C5CA1CAB-0038-4CBF-8938-445F0A576433Q28263224-D09C88E6-607A-400D-9A59-3FFD1BE5120CQ28264735-A3816780-988F-489D-BF92-2DF93F9F3CF1Q28272877-F0A0BF38-0BB6-4DD1-BEF3-B7EA048D8222Q28273071-EFA66903-7D09-401C-94EF-B5858893B4ECQ28273083-096532DD-9F2D-499F-8104-153E0157A8E2Q28273870-470C9D5B-325D-4D7B-B84E-215E4E871FC6Q28274561-D52161B7-F721-4DDA-A927-F92A1446FEABQ28276026-D83B0C63-A569-45CC-80B5-0FF6B5E4A365Q28278684-74A40A68-3ECF-457E-A1EA-7685389AA3F8Q28282812-EE074A3F-8589-4AB8-9CB1-8AFDAAC3FDF4Q28282822-3393F0CD-183C-406C-8477-CB29F73B60B7Q28282834-3CC4CE87-0096-41A3-A5F3-D38FE9F550AA
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Informa
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Expert Opinion on Therapeutic Targets
@ast
Expert Opinion on Therapeutic Targets
@da
Expert Opinion on Therapeutic Targets
@de
Expert Opinion on Therapeutic Targets
@en
Expert Opinion on Therapeutic Targets
@es
Expert Opinion on Therapeutic Targets
@fi
Expert Opinion on Therapeutic Targets
@fr
Expert Opinion on Therapeutic Targets
@it
Expert Opinion on Therapeutic Targets
@nb
Expert Opinion on Therapeutic Targets
@nl
type
label
Expert Opinion on Therapeutic Targets
@ast
Expert Opinion on Therapeutic Targets
@da
Expert Opinion on Therapeutic Targets
@de
Expert Opinion on Therapeutic Targets
@en
Expert Opinion on Therapeutic Targets
@es
Expert Opinion on Therapeutic Targets
@fi
Expert Opinion on Therapeutic Targets
@fr
Expert Opinion on Therapeutic Targets
@it
Expert Opinion on Therapeutic Targets
@nb
Expert Opinion on Therapeutic Targets
@nl
prefLabel
Expert Opinion on Therapeutic Targets
@ast
Expert Opinion on Therapeutic Targets
@da
Expert Opinion on Therapeutic Targets
@de
Expert Opinion on Therapeutic Targets
@en
Expert Opinion on Therapeutic Targets
@es
Expert Opinion on Therapeutic Targets
@fi
Expert Opinion on Therapeutic Targets
@fr
Expert Opinion on Therapeutic Targets
@it
Expert Opinion on Therapeutic Targets
@nb
Expert Opinion on Therapeutic Targets
@nl
P236
P243
P3181
P4616
P101
P1055
P1058
P1144
2002243135
P1156
P123
P1250
P1277
P1476
Expert Opinion on Therapeutic Targets
@en
P236
P243
P3181
P407
P571
1997-01-01T00:00:00Z